Domača stranDSKYF • OTCMKTS
add
Daiichi Sankyo Co Ltd
Delnica
Vodilno podjetje na področju varovanja okoljaVrednostni papir, ki kotira v ZDASedež podjetja: JP
Vodilno podjetje na področju varovanja okoljaVrednostni papir, ki kotira v ZDASedež podjetja: JPPrejšnji trg. dan.
30,19 $
Dnevni razpon
27,89 $ - 30,95 $
Letni razpon
25,95 $ - 44,64 $
Tržna kapitalizacija
55,89 mrd. USD
Povprečni obseg
4,62 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
TYO
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (JPY) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 446,55 mrd. | 18,92 % |
Stroški poslovanja | 254,60 mrd. | 10,82 % |
Čisti dohodek | 61,29 mrd. | 53,26 % |
Čista dobičkovnost prihodkov | 13,73 | 28,92 % |
Earnings per share | — | — |
EBITDA | 110,60 mrd. | 69,06 % |
Efektivna davčna stopnja | 25,60 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (JPY) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 707,67 mrd. | 19,79 % |
Skupna sredstva | 3,30 bil. | 24,46 % |
Skupne obveznosti | 1,67 bil. | 58,69 % |
Celoten lastniški kapital | 1,62 bil. | — |
Shares outstanding | 1,90 mrd. | — |
Razmerje P/B | 0,04 | — |
Donosnost sredstev | 6,97 % | — |
Donosnost kapitala | 13,24 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (JPY) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 61,29 mrd. | 53,26 % |
Denar iz dejavnosti | 33,49 mrd. | 284,55 % |
Denar iz naložb | −10,87 mrd. | −108,72 % |
Denar iz financiranja | −78,62 mrd. | −75,67 % |
Neto sprememba denarnih sredstev | −97,59 mrd. | −237,26 % |
Prost denarni tok | 53,27 mrd. | −46,31 % |
Vizitka
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Generalni direktor
Datum ustanovitve
28. sep. 2005
Sedež organizacije
Spletno mesto
Zaposleni
18.726
